Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Plus Dexamethasone in Previously Treated Multiple Myeloma
NCT00420849Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Nov 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Nov 2006; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00420849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420849.